Bionano Genomics (BNGO) Leases (2021 - 2026)

Bionano Genomics' Leases history runs 6 years deep, the most recent figure standing at $3.1 million for Q1 2026.

• In Q1 2026, Leases fell 5.76% year-over-year to $3.1 million; the TTM figure through Mar 2026 stood at $3.1 million (down 5.76% YoY), while the FY2025 annual figure was $3.2 million, down 2.49% from the prior year.
• Leases came in at $3.1 million for Q1 2026 at Bionano Genomics, down from $3.2 million in the prior quarter.
• In the past five years, Leases ranged from a high of $7.1 million in Q1 2023 to a low of $2.8 million in Q3 2024.
• A 5-year average of $4.3 million and a median of $3.5 million in 2023 frame the typical range for Leases.
• On a YoY basis, Leases climbed as much as 17.05% in 2024 and fell as far as 54.08% in 2024.
• Bionano Genomics' Leases stood at $3.7 million in 2022, then slipped by 5.5% to $3.5 million in 2023, then decreased by 5.82% to $3.3 million in 2024, then dropped by 2.49% to $3.2 million in 2025, then decreased by 4.82% to $3.1 million in 2026.
• According to Business Quant data, Leases over the past three periods registered $3.1 million, $3.2 million, and $3.1 million for Q1 2026, Q4 2025, and Q3 2025 respectively.

Peer Comparison